oxidopamine and nadp
oxidopamine has been researched along with nadp in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Girardier, L; Mory, G; Seydoux, J | 1 |
| Ceña, V; Galindo, MF; González-García, C; Jordán, J | 1 |
| Dunbar, GL; Haik, KL; Hargrove, C; Mazei-Robison, M; Patton, J; Sandstrom, MI; Shear, DA | 1 |
| Guerra, MJ; Labandeira-Garcia, JL; Muñoz, A; Parga, JA; Rey, P; Rodriguez-Pallares, J | 1 |
| Choi, JG; Du, XF; Eo, H; Hong, SP; Huh, E; Jeong, JS; Kim Pak, Y; Kwon, Y; Oh, MS; Sim, Y; Soh, HY | 1 |
Other Studies
5 other study(ies) available for oxidopamine and nadp
| Article | Year |
|---|---|
Short-lived denervation of brown adipose tissue of the rat induced by chemical sympathetic denervation.
Topics: Adipose Tissue, Brown; Animals; Caprylates; DNA; Electric Stimulation; Guanethidine; Hydroxydopamines; Male; NAD; NADP; Norepinephrine; Organ Size; Oxidation-Reduction; Oxidopamine; Rats; Rats, Inbred Strains; Sympathectomy, Chemical | 1981 |
Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation.
Topics: Animals; Antioxidants; Caspases; Cattle; Cells, Cultured; Chromaffin Cells; Dose-Response Relationship, Drug; Hydrogen Peroxide; Mitochondria; NAD; NADP; Oxidation-Reduction; Oxidopamine; Quinones; Reactive Oxygen Species | 2003 |
7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease.
Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dopamine; Indazoles; Learning Disabilities; Male; Maze Learning; NADP; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Spatial Behavior; Substantia Nigra | 2008 |
Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.
Topics: Adrenergic Agents; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Brain; Cells, Cultured; Dopamine; Fluorescent Antibody Technique; Immunohistochemistry; Microglia; NADP; Nerve Degeneration; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Protective effects of DA-9805 on dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity in the models of Parkinson's disease.
Topics: Animals; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Male; Mice; Mice, Inbred ICR; NADP; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease; PC12 Cells; Plant Extracts; Plant Preparations; Rats | 2019 |